
Respiratory Pathogen Testing Kits Market Report and Forecast 2025-2034
Description
The global respiratory pathogen testing kits market was valued at USD 4.33 Billion in 2024, driven by the rising incidence of respiratory infections and advancements in technology across the globe. The market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2025-2034, with the values likely to reach USD 7.54 Billion by 2034.
Respiratory Pathogen Testing Kits Market Overview
Respiratory pathogen testing kits are diagnostic kits that can be used to determine infections caused by respiratory pathogens, including viruses, bacteria, or fungi. It helps to detect the cause of diseases related to the respiratory system, including influenza, COVID-19, and pneumonia, which can be done by testing respiratory samples. The rising burden of respiratory infections and advancements in diagnostic technologies are fuelling market growth. Moreover, the growing awareness of early disease detection, with a need for precise and rapid testing, is further driving demand across hospitals, clinics, and diagnostic laboratories globally.
Respiratory Pathogen Testing Kits Market Growth Drivers
Rising Respiratory Infections Incidence to Elevate the Market Value
The rising incidence of respiratory pathogens, including influenza, COVID-19, and RSV, is a major growth driver in the market. These infections are highly influenced by seasonal changes, urbanization, and enhanced human mobility, which have increased the need for rapid and accurate diagnostic solutions. Governments and healthcare institutions are giving much importance to early detection to curb outbreaks, which is driving the market forward.
Advancements in Technology Likely to Augment Respiratory Pathogen Testing Kits Market Demand
Technological advancements in diagnostic testing, including innovations in PCR, molecular diagnostics, and rapid antigen tests, are driving growth in the market. Better accuracy, reduced turnaround times, and user-friendly designs have revolutionized pathogen detection. The integration of artificial intelligence and automation in diagnostic platforms further optimizes efficiency, meeting the growing demand for advanced and scalable testing solutions globally.
Respiratory Pathogen Testing Kits Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growth in Point-of-Care Testing
The demand for point-of-care testing kits has increased as their application allows for immediate results in the outpatient setting. This reduces waiting time and enhances treatment initiation. The convenience of at-home testing and faster results have revolutionized respiratory diagnostics, especially for urgent care facilities and remote regions.
Rising Demand for Rapid Testing
Rapid diagnostic tests are becoming more critical for the management of respiratory infections. Kits that yield results within an hour are becoming increasingly popular among healthcare providers, especially during the peak infection periods.
Expanding Use in Emerging Markets
Increased healthcare infrastructure and rising awareness of respiratory diseases in emerging markets are expanding the use of respiratory pathogen testing kits. The shift is due to increased government support and efforts to expand testing access in remote regions.
Integration with Digital Health Solutions
Respiratory pathogen testing kits are increasingly being integrated with digital health platforms. Mobile applications and online platforms help collect, store, and analyze results, thus enhancing patient management. Digital solutions also enable remote monitoring, outbreak tracking, and contact tracing.
Respiratory Pathogen Testing Kits Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Segmentation Based on Product Type to Witness Substantial Growth
Based on product type, the market is divided into RT PCR kits, ELISA kits, and others. RT-PCR kits are likely to have a significant share in the global market because of their accuracy and reliability. RT-PCR kits are gold-standard detection tools for viral infections, such as COVID-19 and influenza, and therefore, they are widely used in clinical diagnostics. They also play a very vital role in critical care diagnostics.
Respiratory Pathogen Testing Kits Market Analysis by Region
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in North America is expected to grow significantly owing to the presence of a well-established healthcare infrastructure, as well as enhanced disease awareness. The rapid adoption of advanced diagnostic technologies, along with government support toward public health initiatives, is contributing to market growth in the region.
Leading Players in the Respiratory Pathogen Testing Kits Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific
Thermo Fisher Scientific was established in 2006 and has its headquarters in Waltham, Massachusetts. They are a global player in laboratory equipment and diagnostics, including products for the respiratory pathogen testing market. The company offers Applied Biosystems real-time PCR solutions for detecting multiple respiratory pathogens, such as SARS-CoV-2, Flu A, Flu B, and RSV.
Abbott Laboratories
Abbott Laboratories was established in 1888 and headquartered in Abbott Park, Illinois USA. It is a global leader in healthcare and diagnostics. In the respiratory pathogen testing kits market, their product portfolio includes the Alinity m and Realtime m2000 systems, offering advanced molecular diagnostics for detecting respiratory pathogens like SARS-CoV-2, influenza, and RSV.
Becton, Dickinson and Company
BD was established in 1897 and has its headquarters in Franklin Lakes, New Jersey. It is a leading player in the global respiratory pathogen testing kits market. Their BD MAX™ Respiratory Viral Panel allows for the detection of SARS-CoV-2, influenza A, influenza B, and RSV from a single specimen, enhancing diagnostic efficiency and speed.
F. Hoffmann La Roche Ltd.
Roche, founded in 1896 and headquartered in Basel, Switzerland, is a leader in the global respiratory pathogen testing kits market. Their product Cobas® Eplex Respiratory Pathogen Panel 2 (RP2), detects over 20 respiratory viruses and bacteria, including SARS-CoV-2. It offers rapid diagnosis and aids in informed patient care decisions.
Other key players in the market include Danaher Corporation, BioMerieux Inc., and Altona Diagnostics.
Key Questions Answered in the Respiratory Pathogen Testing Kits Market Report
Respiratory Pathogen Testing Kits Market Overview
Respiratory pathogen testing kits are diagnostic kits that can be used to determine infections caused by respiratory pathogens, including viruses, bacteria, or fungi. It helps to detect the cause of diseases related to the respiratory system, including influenza, COVID-19, and pneumonia, which can be done by testing respiratory samples. The rising burden of respiratory infections and advancements in diagnostic technologies are fuelling market growth. Moreover, the growing awareness of early disease detection, with a need for precise and rapid testing, is further driving demand across hospitals, clinics, and diagnostic laboratories globally.
Respiratory Pathogen Testing Kits Market Growth Drivers
Rising Respiratory Infections Incidence to Elevate the Market Value
The rising incidence of respiratory pathogens, including influenza, COVID-19, and RSV, is a major growth driver in the market. These infections are highly influenced by seasonal changes, urbanization, and enhanced human mobility, which have increased the need for rapid and accurate diagnostic solutions. Governments and healthcare institutions are giving much importance to early detection to curb outbreaks, which is driving the market forward.
Advancements in Technology Likely to Augment Respiratory Pathogen Testing Kits Market Demand
Technological advancements in diagnostic testing, including innovations in PCR, molecular diagnostics, and rapid antigen tests, are driving growth in the market. Better accuracy, reduced turnaround times, and user-friendly designs have revolutionized pathogen detection. The integration of artificial intelligence and automation in diagnostic platforms further optimizes efficiency, meeting the growing demand for advanced and scalable testing solutions globally.
Respiratory Pathogen Testing Kits Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growth in Point-of-Care Testing
The demand for point-of-care testing kits has increased as their application allows for immediate results in the outpatient setting. This reduces waiting time and enhances treatment initiation. The convenience of at-home testing and faster results have revolutionized respiratory diagnostics, especially for urgent care facilities and remote regions.
Rising Demand for Rapid Testing
Rapid diagnostic tests are becoming more critical for the management of respiratory infections. Kits that yield results within an hour are becoming increasingly popular among healthcare providers, especially during the peak infection periods.
Expanding Use in Emerging Markets
Increased healthcare infrastructure and rising awareness of respiratory diseases in emerging markets are expanding the use of respiratory pathogen testing kits. The shift is due to increased government support and efforts to expand testing access in remote regions.
Integration with Digital Health Solutions
Respiratory pathogen testing kits are increasingly being integrated with digital health platforms. Mobile applications and online platforms help collect, store, and analyze results, thus enhancing patient management. Digital solutions also enable remote monitoring, outbreak tracking, and contact tracing.
Respiratory Pathogen Testing Kits Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- RT PCR Kits
- ELISA Kits
- Others
- NAAT (Nucleic Acid Amplification)
- Immunoassays
- Others
- Enterovirus Infection
- Human Coronavirus Infection
- Influenza Virus Infection
- Respiratory Syncytial Virus Infection
- Others
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Product Type to Witness Substantial Growth
Based on product type, the market is divided into RT PCR kits, ELISA kits, and others. RT-PCR kits are likely to have a significant share in the global market because of their accuracy and reliability. RT-PCR kits are gold-standard detection tools for viral infections, such as COVID-19 and influenza, and therefore, they are widely used in clinical diagnostics. They also play a very vital role in critical care diagnostics.
Respiratory Pathogen Testing Kits Market Analysis by Region
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in North America is expected to grow significantly owing to the presence of a well-established healthcare infrastructure, as well as enhanced disease awareness. The rapid adoption of advanced diagnostic technologies, along with government support toward public health initiatives, is contributing to market growth in the region.
Leading Players in the Respiratory Pathogen Testing Kits Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific
Thermo Fisher Scientific was established in 2006 and has its headquarters in Waltham, Massachusetts. They are a global player in laboratory equipment and diagnostics, including products for the respiratory pathogen testing market. The company offers Applied Biosystems real-time PCR solutions for detecting multiple respiratory pathogens, such as SARS-CoV-2, Flu A, Flu B, and RSV.
Abbott Laboratories
Abbott Laboratories was established in 1888 and headquartered in Abbott Park, Illinois USA. It is a global leader in healthcare and diagnostics. In the respiratory pathogen testing kits market, their product portfolio includes the Alinity m and Realtime m2000 systems, offering advanced molecular diagnostics for detecting respiratory pathogens like SARS-CoV-2, influenza, and RSV.
Becton, Dickinson and Company
BD was established in 1897 and has its headquarters in Franklin Lakes, New Jersey. It is a leading player in the global respiratory pathogen testing kits market. Their BD MAX™ Respiratory Viral Panel allows for the detection of SARS-CoV-2, influenza A, influenza B, and RSV from a single specimen, enhancing diagnostic efficiency and speed.
F. Hoffmann La Roche Ltd.
Roche, founded in 1896 and headquartered in Basel, Switzerland, is a leader in the global respiratory pathogen testing kits market. Their product Cobas® Eplex Respiratory Pathogen Panel 2 (RP2), detects over 20 respiratory viruses and bacteria, including SARS-CoV-2. It offers rapid diagnosis and aids in informed patient care decisions.
Other key players in the market include Danaher Corporation, BioMerieux Inc., and Altona Diagnostics.
Key Questions Answered in the Respiratory Pathogen Testing Kits Market Report
- What was the respiratory pathogen testing kits market value in 2024?
- What is the respiratory pathogen testing kits market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on product type?
- What is the market segmentation based on technology?
- What is the market breakup based on application?
- What is the market breakup based on the end user?
- What major factors are aiding the respiratory pathogen testing kits market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the respiratory pathogen testing kits market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Respiratory Pathogen Testing Kits Market Overview
- 3.1 Global Respiratory Pathogen Testing Kits Market Historical Value (2018-2024)
- 3.2 Global Respiratory Pathogen Testing Kits Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Respiratory Pathogen Testing Kits Market Landscape*
- 5.1 Global Respiratory Pathogen Testing Kits Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Respiratory Pathogen Testing Kits Market: Service Landscape
- 5.2.1 Analysis by Product Type
- 5.2.2 Analysis by Technology
- 5.2.3 Analysis by Platform
- 5.2.4 Analysis by Application
- 6 Global Respiratory Pathogen Testing Kits Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Respiratory Pathogen Testing Kits Market Segmentation (218-2034)
- 7.1 Global Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 7.1.1 Market Overview
- 7.1.2 RT PCR Kits
- 7.1.3 ELISA Kits
- 7.1.4 Others
- 7.2 Global Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 7.2.1 Market Overview
- 7.2.2 NAAT (Nucleic Acid Amplification)
- 7.2.3 Immunoassays
- 7.2.4 Others
- 7.3 Global Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Enterovirus Infection
- 7.3.3 Human Coronavirus Infection
- 7.3.4 Influenza Virus Infection
- 7.3.5 Respiratory Syncytial Virus Infection
- 7.3.6 Others
- 7.4 Global Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Hospitals
- 7.4.3 Specialty Clinics
- 7.4.4 Diagnostic Centers
- 7.5 Global Respiratory Pathogen Testing Kits Market (2018-2034) by Region
- 7.5.1 Market Overview
- 7.5.2 North America
- 7.5.3 Europe
- 7.5.4 Asia Pacific
- 7.5.5 Latin America
- 7.5.6 Middle East and Africa
- 8 North America Respiratory Pathogen Testing Kits Market (218-2034)
- 8.1 North America Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 8.1.1 Market Overview
- 8.1.2 RT PCR Kits
- 8.1.3 ELISA Kits
- 8.1.4 Others
- 8.2 North America Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 8.2.1 Market Overview
- 8.2.2 NAAT (Nucleic Acid Amplification)
- 8.2.3 Immunoassays
- 8.3 North America Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Enterovirus Infection
- 8.3.3 Human Coronavirus Infection
- 8.3.4 Influenza Virus Infection
- 8.3.5 Respiratory Syncytial Virus Infection
- 8.3.6 Others
- 8.4 North America Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Hospitals
- 8.4.3 Specialty Clinics
- 8.4.4 Diagnostic Centers
- 8.5 North America Respiratory Pathogen Testing Kits Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.1.1 United States of America Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 8.5.2 Canada
- 8.5.2.1 Canada Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 9 Europe Respiratory Pathogen Testing Kits Market (218-2034)
- 9.1 Europe Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 9.1.1 Market Overview
- 9.1.2 RT PCR Kits
- 9.1.3 ELISA Kits
- 9.1.4 Others
- 9.2 Europe Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 9.2.1 Market Overview
- 9.2.2 NAAT (Nucleic Acid Amplification)
- 9.2.3 Immunoassays
- 9.3 Europe Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Enterovirus Infection
- 9.3.3 Human Coronavirus Infection
- 9.3.4 Influenza Virus Infection
- 9.3.5 Respiratory Syncytial Virus Infection
- 9.3.6 Others
- 9.4 Europe Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 9.4.1 Market Overview
- 9.4.2 Hospitals
- 9.4.3 Specialty Clinics
- 9.4.4 Diagnostic Centers
- 9.5 Europe Respiratory Pathogen Testing Kits Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.1.1 United Kingdom Pathogen Testing Kits Market (2018-2034) by Product Type
- 9.5.2 Germany
- 9.5.2.1 Germany Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 9.5.3 France
- 9.5.3.1 France Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 9.5.4 Italy
- 9.5.4.1 Italy Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 9.5.5 Others
- 10 Asia Pacific Respiratory Pathogen Testing Kits Market (218-2034)
- 10.1 Asia Pacific Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 10.1.1 Market Overview
- 10.1.2 RT PCR Kits
- 10.1.3 ELISA Kits
- 10.1.4 Others
- 10.2 Asia Pacific Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 10.2.1 Market Overview
- 10.2.2 NAAT (Nucleic Acid Amplification)
- 10.2.3 Immunoassays
- 10.3 Asia Pacific Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Enterovirus Infection
- 10.3.3 Human Coronavirus Infection
- 10.3.4 Influenza Virus Infection
- 10.3.5 Respiratory Syncytial Virus Infection
- 10.3.6 Others
- 10.4 Asia Pacific Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 10.4.1 Market Overview
- 10.4.2 Hospitals
- 10.4.3 Specialty Clinics
- 10.4.4 Diagnostic Centers
- 10.5 Asia Pacific Respiratory Pathogen Testing Kits Market (2018-2034) by Country
- 10.5.1 China
- 10.5.1.1 China Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 10.5.2 Japan
- 10.5.2.1 Japan Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 10.5.3 India
- 10.5.3.1 India Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 10.5.4 Australia
- 10.5.4.1 Australia Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 10.5.5 Others
- 11 Latin America Respiratory Pathogen Testing Kits Market (218-2034)
- 11.1 Latin America Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 11.1.1 Market Overview
- 11.1.2 RT PCR Kits
- 11.1.3 ELISA Kits
- 11.1.4 Others
- 11.2 Latin America Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 11.2.1 Market Overview
- 11.2.2 NAAT (Nucleic Acid Amplification)
- 11.2.3 Immunoassays
- 11.3 Latin America Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Enterovirus Infection
- 11.3.3 Human Coronavirus Infection
- 11.3.4 Influenza Virus Infection
- 11.3.5 Respiratory Syncytial Virus Infection
- 11.3.6 Others
- 11.4 Latin America Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 11.4.1 Market Overview
- 11.4.2 Hospitals
- 11.4.3 Specialty Clinics
- 11.4.4 Diagnostic Centers
- 11.5 Latin America Respiratory Pathogen Testing Kits Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.1.1 Brazil Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 11.5.2 Argentina
- 11.5.2.1 Argentina Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 11.5.3 Mexico
- 11.5.3.1 Mexico Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 11.5.4 Others
- 12 Middle East and Africa Respiratory Pathogen Testing Kits Market (218-2034)
- 12.1 Middle East and Africa Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 12.1.1 Market Overview
- 12.1.2 RT PCR Kits
- 12.1.3 ELISA Kits
- 12.1.4 Others
- 12.2 Middle East and Africa Respiratory Pathogen Testing Kits Market (2018-2034) by Technology
- 12.2.1 Market Overview
- 12.2.2 NAAT (Nucleic Acid Amplification)
- 12.2.3 Immunoassays
- 12.3 Middle East and Africa Respiratory Pathogen Testing Kits Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Enterovirus Infection
- 12.3.3 Human Coronavirus Infection
- 12.3.4 Influenza Virus Infection
- 12.3.5 Respiratory Syncytial Virus Infection
- 12.3.6 Others
- 12.4 Middle East and Africa Respiratory Pathogen Testing Kits Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Hospitals
- 12.4.3 Specialty Clinics
- 12.4.4 Diagnostic Centers
- 12.5 Middle East and Africa Respiratory Pathogen Testing Kits Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.1.1 Saudi Arabia Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 12.5.2 United Arab Emirates
- 12.5.2.1 United Arab Emirates Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 12.5.3 Nigeria
- 12.5.3.1 Nigeria Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 12.5.4 South Africa
- 12.5.4.1 South Africa Respiratory Pathogen Testing Kits Market (2018-2034) by Product Type
- 12.5.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Product Type
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Thermo Fisher Scientific
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Abbott Laboratories
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 Danaher Corporation
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 Becton, Dickinson and Company
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 F. Hoffmann La Roche Ltd.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 bioMerieux Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 Altona Diagnostics
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.